Meeting
2017 ASCO Annual Meeting
Pathologic complete response rate after neoadjuvant chemoradiation in patients with locally advanced rectal cancer affects survival in patients with prolonged radiation-surgery interval.
Authors
Benjamin Mitchell Motz
Levine Cancer Institute, Charlotte, NC
Benjamin Mitchell Motz , Patrick Daniel Lorimer , Danielle Boselli , I'sis N Perry , Joshua S. Hill , Jonathan C. Salo
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer–Local-Regional Disease
Citation
J Clin Oncol 35, 2017 (suppl; abstr 3608)
DOI
10.1200/JCO.2017.35.15_suppl.3608
Abstract #
3608
Poster Bd #
231
Abstract Disclosures
Similar Posters
Poster
2017 Gastrointestinal Cancers Symposium
Effect of adjuvant chemotherapy following pathologic complete response on long-term survival in rectal cancer: A propensity score matched analysis.
First Author: Ali Mokdad
Poster
2023 ASCO Gastrointestinal Cancers Symposium
What genes predict response to neoadjuvant chemoradiation in locally advanced rectal cancer? A systematic review based on gene expression profiling.
First Author: Michelle Or
Poster
2021 ASCO Annual Meeting
Total neoadjuvant treatment versus standard chemoradiation to increase the sphincter preservation rate for distal locally advanced rectal cancer (TESS).
First Author: Weiwei Xiao
Poster
2021 ASCO Annual Meeting
Long-term outcome of a phase III trial on neoadjuvant chemoradiation with capecitabine and irinotecan in patients with locally advanced rectal cancer: Updated results of the CinClare trial.
First Author: Ji Zhu